Key Takeaways
- Concert Bio’s microbial product candidates showed up to +15.2% yield improvement in hydroponic tomato production during independent trials.
- The trial, conducted by UK-based research group Fyto, tested four candidates on Balconi F1 tomatoes grown in coco coir.
- Two candidates demonstrated strong and consistent yield benefits without compromising fruit quality.
- These products are developed using Concert Bio’s AI-powered microbiome discovery platform.
- Additional commercial trials are now underway in the UK and Netherlands, with further testing in cucumbers also showing promising results.
Concert Bio’s Hydroponic Tomato Biostimulants Validated by Independent Research
Concert Bio, a biotech company focused on microbial solutions for controlled environment agriculture, has announced the results of an independent trial validating the performance of its microbial product candidates in hydroponic tomato production. The study was conducted in partnership with Fyto, a UK-based independent agricultural research organization.
The tested candidates were derived from Concert Bio’s proprietary AI-driven plant microbiome platform, which leverages greenhouse-specific plant-microbiome data to develop microbial formulations targeted at enhancing crop yield in hydroponic systems.
“These findings strongly support the impact of our AI-discovered microbial treatments in high-value, commercial greenhouse production systems,” said the company.
Concert Bio’s Candidate 2 Achieves Over 15% Yield Increase
In the trial, four microbial product candidates were applied to Balconi F1 tomato plants grown in coco coir. The standout result came from Candidate 2, which delivered a +15.2% increase in total fresh fruit yield, a significant gain in commercial greenhouse environments where even a 1–5% improvement is considered meaningful.
| Candidate | Yield Impact | Notes |
|---|---|---|
| Candidate 2 | +15.2% | Most significant overall yield improvement |
| Candidate 3 | +6.4% | Consistent performance |
| Candidate 4 | Positive early-season | Reduced yield in later harvests |
| Candidate 1 | Control/reference | Baseline |
Importantly, Brix levels remained stable, confirming that the treatments did not compromise fruit quality.
Platform Success Expands to Cucumbers, New Trials Underway
Beyond tomatoes, Concert Bio has also seen success in cucumber production, with both in-house and independent testing confirming notable yield gains. These results underline the broader potential of the company’s microbial platform across multiple vine crops.
Concert Bio is now:
- Conducting commercial trials in the UK and Netherlands
- Testing next-generation product candidates derived from newly trained AI models
- Expanding its microbial library and platform capability for hydroponic and greenhouse environments
